Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -0.38% | +7.22% | -7.96% |
May. 16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
May. 16 | Monte Rosa Therapeutics Prices $100 Million Public Offering | MT |
Financials (USD)
Sales 2024 * | 6.8M | Sales 2025 * | 6.43M | Capitalization | 318M |
---|---|---|---|---|---|
Net income 2024 * | -139M | Net income 2025 * | -161M | EV / Sales 2024 * | 28.9 x |
Net cash position 2024 * | 122M | Net cash position 2025 * | 171M | EV / Sales 2025 * | 22.8 x |
P/E ratio 2024 * |
-2.32
x | P/E ratio 2025 * |
-2.45
x | Employees | 130 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.12% |
Latest transcript on Monte Rosa Therapeutics, Inc.
1 day | -0.38% | ||
1 week | +7.22% | ||
Current month | -2.26% | ||
1 month | -12.16% | ||
3 months | -12.75% | ||
6 months | +55.22% | ||
Current year | -7.96% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Chief Operating Officer | - | 21-02-28 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 20-08-31 |
Christine Siu
BRD | Director/Board Member | 47 | 20-11-30 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.2 | -0.38% | 153,345 |
24-05-16 | 5.22 | -0.19% | 1,290,105 |
24-05-15 | 5.23 | +4.60% | 129,472 |
24-05-14 | 5 | +1.01% | 80,678 |
24-05-13 | 4.95 | +2.06% | 260,248 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.96% | 318M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- GLUE Stock